Strategic Planning

Sidekick, NHS< AI
By  Tammy Lovell 05:13 am June 17, 2022
Sidekick Health and Lilly collaborate to support breast cancer patients Digital therapeutics (DTx) startup Sidekick Health has announced an integrated solution in conjunction with pharma firm Eli Lilly and Company for patients with breast cancer. Through Sidekick’s platform, patients will be given access to a tailored digital treatment plan to promote behaviour modification and overcome barriers...
McKinsey & Co, HealthTech Network, HIMSS22 Europe, remote monitoring, digital surgery
By  Tammy Lovell 06:10 am June 7, 2022
When it comes to digitalising healthcare organisations there are two major pitfalls. If digitalisation is pursued in an IT and technology driven way, it can lead to painful implementations which leave clinicians scratching their heads. On the other hand, coming from a use case point of view can lead to endless pilot schemes that never get scaled up – something Tobias Silberzahn, partner at...
Sleepio, NHS, digital therapeutics, DTx, insomnia
By  Tammy Lovell 06:42 am May 21, 2022
The National Institute for Health and Care Excellence (NICE) has recommended the Sleepio app as an effective alternative to sleeping pills. In its guidance, NICE states the app, created by digital therapeutics (DTx) firm Big Health, is a safe and effective treatment for people suffering from insomnia.   It adds that the app could save the NHS money and reduce prescriptions of medicines such as...
Sidekick Health, Pfizer, digital therapeutics, atopic dermatitis
By  Tammy Lovell 01:38 am May 20, 2022
Digital therapeutics firm, Sidekick Health has joined forces with pharma giant Pfizer to launch an integrated digital therapeutics solution for Atopic Dermatitis (AD). The solution will be rolled-out in the UK first, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later this year. This marks the next phase of a growing collaboration between Sidekick and Pfizer to...
Babylon,
By  Tammy Lovell 11:56 am May 19, 2022
Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme Biotechnology firm Oxford Drug Design Limited (ODD) has raised £2.2M in funding from existing investors ACF Investors, o2h Ventures, Meltwind Advisory, several returning angels and new investors and the US-based R42 Group. The Oxford University spinout has created an artificial intelligence (AI) AI proprietary platform...
ORCHA, digital therapeutics, DTx Project, digital health patient engagement, mental health, COVID-19
By  Tammy Lovell 07:11 am May 17, 2022
Demand for mental health services has soared since the COVID-19 pandemic. In the UK alone an estimated 1.6 million people are awaiting treatment, while a further eight million who do not qualify for NHS help are experiencing day-to-day challenges. Increasingly digital therapeutics (DTx) are being considered as an option to fill the gaps in healthcare provision. They have the potential to be woven...
UAE, app, funding
By  Tammy Lovell 01:22 am May 13, 2022
Free mental health app available to 1 million South Yorkshire NHS users An emotional wellness app is being offered to over 16s in the UK's South Yorkshire for free, to help manage low moods, reduce stress and improve sleep. The myStrength app has been commissioned by the South Yorkshire Integrated Care System (ICS) and is being delivered by Consultant Connect, part of the Teladoc Group. Users are...
Sidekick Health, Series B, digital therapeutics, Novator Ventures, Wellington Partners, Asabys Partners, Frumtak Ventures
By  Tammy Lovell 01:42 am May 5, 2022
Digital therapeutics (DTx) firm Sidekick Health today announced a raise of $55 million (€52M) in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a US-based strategic investor that will be revealed at a later stage. WHAT IT DOES Sidekick develops and...
Moonhub, AI, Ascenti, ELARA, skin cancer, Wellola, NHS
By  Tammy Lovell 01:59 am April 29, 2022
AI tool receives UK regulatory approval to support urgent skin cancer cases Artificial intelligence (AI) dermatology firm Skin Analytics has received Class IIA status under the UK Medical Device Regulations 2002 for its device, DERM. DERM uses machine learning to support clinicians in recognising the most common malignant, pre-malignant and benign skin lesions.  James Hamlyn, quality assurance...
VideoVisit, Elsevier, Hampleton Partners, Main Capital Partners, CliniSys
By  Tammy Lovell 11:52 am April 21, 2022
Main Capital Partners acquires Finnish virtual healthcare specialist VideoVisit Software investor Main Capital Partners has announced the acquisition of a majority stake in virtual healthcare provider VideoVisit.   VideoVisit has more than 200 municipalities in Finland as customers, including Helsinki, Espoo, Vantaa, Tampere and Turku. The firm provides a software platform designed to digitalise...